144 related articles for article (PubMed ID: 17566558)
21. The new age of healthcare.
Laskaris JX
Radiol Manage; 2002; 24(6):14-6. PubMed ID: 12510605
[No Abstract] [Full Text] [Related]
22. In praise of toolmakers.
Fenselau C
J Proteome Res; 2009 May; 8(5):2135. PubMed ID: 19309079
[No Abstract] [Full Text] [Related]
23. Proteomics' new order.
Nature; 2005 Sep; 437(7056):169-70. PubMed ID: 16148893
[No Abstract] [Full Text] [Related]
24. Proteomics technology.
Dominguez DC; Lopes R; Torres ML
Clin Lab Sci; 2007; 20(4):239-44. PubMed ID: 18069450
[TBL] [Abstract][Full Text] [Related]
25. Proteomics from the clinical perspective: many hopes and much debate.
Beretta L
Nat Methods; 2007 Oct; 4(10):785-6. PubMed ID: 17901867
[No Abstract] [Full Text] [Related]
26. Proteomics: the new frontier also for brain tumor research.
Chumbalkar V; Sawaya R; Bogler O
Curr Probl Cancer; 2008; 32(3):143-54. PubMed ID: 18501776
[No Abstract] [Full Text] [Related]
27. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proteomics: the next logical step in molecular phenotyping.
Veenstra TD; Blonder J
Brief Funct Genomic Proteomic; 2009 Mar; 8(2):89. PubMed ID: 19398504
[No Abstract] [Full Text] [Related]
29. Genetic markers: progress and potential for cardiovascular disease.
Gibbons GH; Liew CC; Goodarzi MO; Rotter JI; Hsueh WA; Siragy HM; Pratt R; Dzau VJ
Circulation; 2004 Jun; 109(25 Suppl 1):IV47-58. PubMed ID: 15226250
[No Abstract] [Full Text] [Related]
30. Natural insights for chemical biologists.
Walsh CT
Nat Chem Biol; 2005 Aug; 1(3):122-4. PubMed ID: 16408011
[TBL] [Abstract][Full Text] [Related]
31. Getting personal.
Nature; 2008 Oct; 455(7216):1007. PubMed ID: 18948899
[No Abstract] [Full Text] [Related]
32. Proteomics discovery of biomarkers.
Massé R; Gibbs BF
Methods Biochem Anal; 2005; 45():181-216. PubMed ID: 19235296
[No Abstract] [Full Text] [Related]
33. Mass spectrometry: from proteomics to metabolomics and lipidomics.
Griffiths WJ; Wang Y
Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
[TBL] [Abstract][Full Text] [Related]
34. Accessible genomes move closer.
Hayden EC
Nature; 2008 Oct; 455(7216):1014. PubMed ID: 18948914
[No Abstract] [Full Text] [Related]
35. Ready or not.
Nature; 2008 Apr; 452(7188):666. PubMed ID: 18401360
[No Abstract] [Full Text] [Related]
36. Genetic testing for the spastic paraplegias: drowning by numbers.
Dürr A
Neurology; 2008 Jul; 71(4):236-8. PubMed ID: 18645162
[No Abstract] [Full Text] [Related]
37. Mass Spectrometry-based Proteomics: What is it expecting ahead?
Martinez JLC; Espiño CL; Santos HM
J Proteomics; 2016 Aug; 145():1-2. PubMed ID: 27523791
[No Abstract] [Full Text] [Related]
38. Proteomics in South Africa: current status, challenges and prospects.
Ndimba BK; Thomas LA
Biotechnol J; 2008 Nov; 3(11):1368-74. PubMed ID: 19016510
[TBL] [Abstract][Full Text] [Related]
39. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
Becker JS; Jakubowski N
Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
[TBL] [Abstract][Full Text] [Related]
40. Recreational genomics? Dreams and fears on genetic susceptibility screening.
van Ommen GB; Cornel MC
Eur J Hum Genet; 2008 Apr; 16(4):403-4. PubMed ID: 18354423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
